Optimizing Gastrointestinal Care in the Cancer Patient: A Gastroenterologist’s Toolkit


Optimizing Gastrointestinal Care in the Cancer Patient: A Gastroenterologist’s Toolkit Banner

Add to Calendar Optimizing Gastrointestinal Care in the Cancer Patient: A Gastroenterologist’s Toolkit 9/26/2025 8:00:00 AM 9/26/2025 4:55:00 PM America/New_York For More Details: https://mskcc.cloud-cme.com/course/courseoverview?EID=56200 Description: Early recognition and management of precancerous gastrointestinal (GI) disorders are essential to cancer prevention and early detection. As our understanding of the pathogenesis of these conditions evolves, treatment algorithms continue to advance. In parallel, emerging endoscopic techniques play an increasingly critical role—not only in surveillance, diagnosis, and treatment of early-stage disease, bu... Zuckerman Research Center, 417 East 68th Street false MM/DD/YYYY


Date & Location
Friday, September 26, 2025, 8:00 AM - 4:55 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY

Specialties
Specialties - Colorectal Surgery, Gastroenterology, Gastrointestinal Oncology, Genetic Counseling, Genetics, Hepatology, Interventional Radiology, Medical Oncology, Nurse Practitioner, Nursing, Pathology, Physician Assistant, Surgical Oncology, Surgical Pathology

Overview

Early recognition and management of precancerous gastrointestinal (GI) disorders are essential to cancer prevention and early detection. As our understanding of the pathogenesis of these conditions evolves, treatment algorithms continue to advance. In parallel, emerging endoscopic techniques play an increasingly critical role—not only in surveillance, diagnosis, and treatment of early-stage disease, but also in the palliative care of patients with advanced GI malignancies.

This one-day course will provide a comprehensive update on the diagnosis, management, and surveillance of precancerous and malignant GI disorders, covering the luminal GI tract, liver, and pancreatobiliary system. Topics will include Barrett’s esophagus, gastric intestinal metaplasia, Helicobacter pylori, pancreatic cysts, and inflammatory bowel disease. The course will also explore endoscopic management of GI malignancies, including the role of EUS, as well as the treatment of luminal obstructions, leaks, fistulae, perforations, and endoscopic submucosal dissection (ESD).

Additional sessions will cover nutrition and GI symptom management, including chemotherapy- and radiation-induced GI toxicity, along with GI and interventional radiology (IR) approaches to managing GI bleeding in cancer patients. Liver-related topics will include the evaluation and treatment of abnormal liver chemistries, screening for hepatocellular carcinoma/cholangiocarcinoma, surgical management for cancer in cirrhotic patients, and IR management of portal hypertension complications.

The program will feature expert-led didactic lectures and interactive, case-based discussions to support practical application of key concepts in clinical practice. Following the conclusion of the program, registrants will receive access to a syllabus that includes PDF versions of faculty presentation slides and recorded session videos.

This course is intended for physicians and healthcare professionals—including gastroenterologists, oncologists, geneticists, pathologists, advanced practice providers, nurses, fellows, and residents—who care for patients with gastrointestinal, liver, and pancreaticobiliary disorders. This program will be held exclusively in person at Memorial Sloan Kettering’s Zuckerman Research Center (a virtual attendance option will not be available.)


Objectives
At the conclusion of this course, learners will be able to:

  1. Recognize the diagnosis and management of immunotherapy related GI complications
  2. Describe the role of endoscopy in the surveillance, diagnosis, management and palliation of premalignant and malignant GI disorders
  3. Discuss the management of GI bleeding, nutrition and chemotherapy and radiation-induced GI toxicity in the cancer patient
  4. Explain the evaluation and management of abnormal liver chemistries, screening for hepatocellular carcinoma/cholangiocarcinoma and portal hypertension related complications in the cancer patient

Registration

This course will be offered exclusively in person; a virtual attendance option will not be available.

Registration Fees

  • Physicians (MDs, PhDs, DOs) $300

  • Advanced Practice Providers: $250

  • Nursing and Other Healthcare Professionals: $200

  • Residents, Fellows, and Students*: $100

  • Industry Professionals**: $525

  • MSK Employees: Complimentary

*Registration fees of $100 or less are non-refundable.
**An “industry professional” is defined as any individual—regardless of profession (e.g., MD, PhD, APP, RN)—who is employed by an ineligible company. View our Registration Policy for Industry Professionals for more information.

Registration Discounts: Discounted registration is available for specific groups. If eligible, you will receive further instructions and a promotion code to use during registration. View our Policy on Registration Discounts for more information.

Meals and Accommodations: Continental breakfast, lunch, and refreshment breaks will be provided to attendees. If you have dietary restrictions or require special accommodations to attend in person, please contact us at [email protected] at least one week prior to the course.

Cancellation Policy: For details on our cancellation terms, please review our Cancellation Policy.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 7.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC/CC Recognition Statements

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

  • 7.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program; and

  • 7.00 Lifelong Learning (CME) credit towards the American Board of Pathology’s (ABPath) Continuing Certification program; and

  • 7.00 CME and Self-Assessment requirements of the American Board of Surgery’s (ABS) Continuous Certification program.

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM, ABPath or ABS MOC/CC credit.

An application for ANCC Nursing Contact Hours is currently under review.